• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket

    1/3/24 7:59:21 AM ET
    $ACON
    $ATXG
    $CLDI
    $CLEU
    Medical Specialities
    Health Care
    Professional Services
    Consumer Discretionary
    Get the next $ACON alert in real time by email

    Shares of Trinity Place Holdings Inc. (NYSE:TPHS) rose sharply in pre-market trading.

    The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024.

    Trinity Place shares jumped 80.1% to $0.2056 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Sigma Additive Solutions, Inc.(NASDAQ:SASI) gained 68.6% to $4.89 in pre-market trading. Sigma Additive Solutions was recently granted U.S. patent #11858207: Defect detection for additive manufacturing systems.
    • Carbon Revolution Public Limited Company (NASDAQ:CREV) rose 36.8% to $31.88 in pre-market trading.
    • Rail Vision Ltd. (NASDAQ:RVSN) shares rose 29.5% to $1.62 in pre-market trading after dipping over 15% on Tuesday.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares gained 25.9% to $4.81 in pre-market trading. Roth MKM raised price target on the stock to $40.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) gained 17.2% to $0.2218 in pre-market trading.
    • NexImmune, Inc. (NASDAQ:NEXI) shares rose 13.9% to $2.79 in pre-market trading after gaining over 6% on Tuesday.
    • VolitionRx Limited (NYSE:VNRX) shares climbed 11.4% to $1.17 in pre-market trading after jumping over 46% on Tuesday.
    • Ucommune International Ltd (NASDAQ:UK) shares gained 10.6% to $4.48 in pre-market trading after gaining 9% on Tuesday.
    • GlycoMimetics, Inc. (NASDAQ:GLYC) gained 10.3% to $3.00 in pre-market trading. GlycoMimetics entered into project agreement with Patheon Manufacturing Services, part of Thermo Fisher Scientific.

    Losers

    • Addentax Group Corp. (NASDAQ:ATXG) shares fell 16.8% to $1.23 in pre-market trading.
    • Calidi Biotherapeutics, Inc. (NASDAQ:CLDI) shares fell 13.8% to $1.24 in pre-market trading after declining around 5% on Tuesday.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) shares fell 13.1% to $1.19 in pre-market trading after declining 8% on Tuesday.
    • Pinstripes (NYSE:PNST) shares fell 13% to $11.58 in pre-market trading after surging 22% on Tuesday. Pinstripes and Banyan Acquisition Corporation announced they have closed their previously announced business combination, which was approved by Banyan’s stockholders at a meeting on Dec. 27, 2023.
    • Yoshiharu Global Co. (NASDAQ:YOSH) shares fell 12.4% to $5.96 in pre-market trading after gaining 25% on Tuesday.
    • MediaCo Holding Inc. (NASDAQ:MDIA) shares fell 11.1% to $0.5230 in pre-market trading after jumping around 37% on Tuesday.
    • Aclarion, Inc. (NASDAQ:ACON) shares fell 10% to $0.1853 in pre-market trading. Aclarion announced a 1-for-16 reverse stock split.
    • Signing Day Sports, Inc. (NYSE:SGN) fell 9.7% to $0.9508 in pre-market trading after declining around 7% on Tuesday.
    • Zoomcar Holdings, Inc. (NASDAQ:ZCAR) shares fell 8.4% to $2.74 in pre-market trading after dipping around 19% on Tuesday.
    • Polished.com Inc. (NYSE:POL) fell 8.1% to $8.44 in pre-market trading after jumping 52% on Tuesday.

     

    Now Read This: Cal-Maine Foods, UniFirst And 3 Stocks To Watch Heading Into Wednesday

     

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $ATXG
    $CLDI
    $CLEU

    CompanyDatePrice TargetRatingAnalyst
    VolitionRX Limited
    $VNRX
    4/8/2025$2.50Buy
    H.C. Wainwright
    Virax Biolabs Group Limited
    $VRAX
    3/31/2025$3.00Buy
    H.C. Wainwright
    GlycoMimetics Inc.
    $GLYC
    3/21/2025Overweight
    Cantor Fitzgerald
    GlycoMimetics Inc.
    $GLYC
    7/26/2024Buy → Hold
    TD Cowen
    GlycoMimetics Inc.
    $GLYC
    12/22/2023$12.00Overweight
    CapitalOne
    Carbon Revolution Public Limited
    $CREV
    11/28/2023$84.00Buy
    Craig Hallum
    Calidi Biotherapeutics Inc.
    $CLDI
    11/22/2023$11.00Buy
    H.C. Wainwright
    Calidi Biotherapeutics Inc.
    $CLDI
    10/9/2023$9.00Outperform
    Robert W. Baird
    More analyst ratings

    $ACON
    $ATXG
    $CLDI
    $CLEU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    GC - Volition Diagnostics Plummer Nicholas covered exercise/tax liability with 5,867 shares, decreasing direct ownership by 1% to 414,270 units (SEC Form 4)

    4 - VOLITIONRX LTD (0000093314) (Issuer)

    3/3/26 4:30:25 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Secretary Rootsaert Rodney Gerard covered exercise/tax liability with 3,321 shares, decreasing direct ownership by 1% to 277,941 units (SEC Form 4)

    4 - VOLITIONRX LTD (0000093314) (Issuer)

    3/3/26 4:31:18 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Chief Commercial Officer Forterre Gael covered exercise/tax liability with 2,283 shares, decreasing direct ownership by 0.67% to 336,589 units (SEC Form 4)

    4 - VOLITIONRX LTD (0000093314) (Issuer)

    3/3/26 4:30:33 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACON
    $ATXG
    $CLDI
    $CLEU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Ness Brent bought $62 worth of shares (10 units at $6.20), increasing direct ownership by 1,000% to 11 units (SEC Form 4)

    4 - Aclarion, Inc. (0001635077) (Issuer)

    12/1/25 5:00:02 PM ET
    $ACON
    Medical Specialities
    Health Care

    President and CEO Reynolds Cameron John bought $7,000 worth of shares (20,000 units at $0.35), increasing direct ownership by 0.79% to 2,554,847 units (SEC Form 4)

    4 - VOLITIONRX LTD (0000093314) (Issuer)

    11/17/25 1:12:19 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    President and CEO Reynolds Cameron John bought $56,100 worth of shares (110,000 units at $0.51), increasing direct ownership by 5% to 2,534,847 units (SEC Form 4)

    4 - VOLITIONRX LTD (0000093314) (Issuer)

    10/15/25 4:05:45 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACON
    $ATXG
    $CLDI
    $CLEU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on VolitionRx with a new price target

    H.C. Wainwright initiated coverage of VolitionRx with a rating of Buy and set a new price target of $2.50

    4/8/25 8:02:28 AM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    H.C. Wainwright initiated coverage on Virax Biolabs Group Ltd. with a new price target

    H.C. Wainwright initiated coverage of Virax Biolabs Group Ltd. with a rating of Buy and set a new price target of $3.00

    3/31/25 8:25:16 AM ET
    $VRAX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Cantor Fitzgerald initiated coverage on GlycoMimetics

    Cantor Fitzgerald initiated coverage of GlycoMimetics with a rating of Overweight

    3/21/25 8:14:54 AM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $ATXG
    $CLDI
    $CLEU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SGN Announces BlockchAIn Has Established a Collaboration with Supermicro for AI Data Center Hardware

    SCOTTSDALE, AZ, March 11, 2026 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. ("Signing Day Sports", "SGN" or the "Company") (NYSE:SGN), in connection with the Company's previously announced proposed business combination with One Blockchain LLC ("BlockchAIn LLC"), today announced that BlockchAIn LLC is collaborating with Super Micro Computer, Inc. ("Supermicro") (NASDAQ:SMCI), a publicly traded technology company based in San Jose, California that provides total IT solutions for enterprise, cloud, AI, and 5G/Edge infrastructure, including servers, AI systems, storage, networking, software, and support services. Working together, BlockchAIn LLC intends to deliver an end-to-end AI infrastruct

    3/11/26 8:00:00 AM ET
    $AIB
    $SGN
    $SMCI
    Blank Checks
    Finance
    EDP Services
    Technology

    Sigma Audio Networks, powered by MediaCo, Launches "Alpha Woman" A Bilingual Audio Network Where Her Voice Leads – Women First. Culture Forward.

    Alpha Woman blends contemporary music, culture, and conversation with the voices of relatable personalities, influential women, and cultural tastemakers to create a listening experience that resonates with bilingual, culturally connected women across the United States. Sigma Audio Networks, powered by MediaCo (NASDAQ:MDIA), today announced the launch of Alpha Woman, a new bilingual (English + Spanish) audio network created to celebrate, empower, and connect with the modern multicultural woman. Built around the tagline "Where Her Voice Leads," Alpha Woman delivers a powerful mix of contemporary music, lifestyle programming, cultural conversation, and inspirational voices that reflect the

    3/10/26 2:00:00 PM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    Signing Day Sports Announces Anticipated Closing Date for Business Combination with BlockchAIn Digital Infrastructure

    SCOTTSDALE, AZ, March 10, 2026 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. ("Signing Day Sports" or the "Company") (NYSE:SGN), today announced that the closing of its previously announced proposed business combination (the "Business Combination") with BlockchAIn Digital Infrastructure, Inc. ("BlockchAIn Inc."), One Blockchain LLC ("BlockchAIn LLC," and together with BlockchAIn Inc., "BlockchAIn"), and certain affiliates of BlockchAIn, is anticipated to occur on March 16, 2026, subject to stockholder approval and other closing conditions. The closing of the transaction is anticipated to occur prior to the commencement of regular trading hours on March 16, 2026. At the time of closing, Sig

    3/10/26 8:00:00 AM ET
    $SGN
    EDP Services
    Technology

    $ACON
    $ATXG
    $CLDI
    $CLEU
    SEC Filings

    View All

    SEC Form 425 filed by Signing Day Sports Inc.

    425 - Signing Day Sports, Inc. (0001898474) (Subject)

    3/11/26 8:06:53 AM ET
    $SGN
    EDP Services
    Technology

    Signing Day Sports Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Signing Day Sports, Inc. (0001898474) (Filer)

    3/11/26 8:00:31 AM ET
    $SGN
    EDP Services
    Technology

    SEC Form 425 filed by Signing Day Sports Inc.

    425 - Signing Day Sports, Inc. (0001898474) (Subject)

    3/10/26 8:04:56 AM ET
    $SGN
    EDP Services
    Technology

    $ACON
    $ATXG
    $CLDI
    $CLEU
    Leadership Updates

    Live Leadership Updates

    View All

    Sigma Audio Networks, powered by MediaCo, Launches "Alpha Woman" A Bilingual Audio Network Where Her Voice Leads – Women First. Culture Forward.

    Alpha Woman blends contemporary music, culture, and conversation with the voices of relatable personalities, influential women, and cultural tastemakers to create a listening experience that resonates with bilingual, culturally connected women across the United States. Sigma Audio Networks, powered by MediaCo (NASDAQ:MDIA), today announced the launch of Alpha Woman, a new bilingual (English + Spanish) audio network created to celebrate, empower, and connect with the modern multicultural woman. Built around the tagline "Where Her Voice Leads," Alpha Woman delivers a powerful mix of contemporary music, lifestyle programming, cultural conversation, and inspirational voices that reflect the

    3/10/26 2:00:00 PM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    MediaCo Promotes René Santaella to Chief Growth & Innovation Officer

    Newly Created Role Will Own "Supply + Growth Engines" for TV, Audio and Digital & Streaming MediaCo Holding Inc. (NASDAQ:MDIA), a leading, multicultural multiplatform media company spanning TV, audio, digital and streaming, today announced that it has appointed René Santaella to the newly created role of Chief Growth & Innovation Officer (CGIO), effective today. In this expanded executive role, Santaella will own MediaCo's end-to-end "Supply + Growth Engines" chain that converts content investment into scalable distribution, deeper audience engagement, increased inventory scale and quality, and improved monetization performance across MediaCo's entire portfolio. This press release featur

    3/9/26 9:00:00 AM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    Signing Day Sports Announces Eyal Rozen Named as Chief Operating Officer of BlockchAIn

    SCOTTSDALE, AZ, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. ("Signing Day Sports" or the "Company") (NYSE:SGN), today announced that Eyal Rozen has been named Chief Operating Officer of One Blockchain LLC ("BlockchAIn LLC"), effective January 2026. As previously disclosed, Signing Day Sports entered into a Business Combination Agreement with BlockchAIn Digital Infrastructure, Inc. ("BlockchAIn Inc." and together with BlockchAIn LLC, "BlockchAIn") and certain affiliates of BlockchAIn on May 27, 2025, as amended on November 10, 2025 and December 21, 2025. Under the agreement, Signing Day Sports and BlockchAIn LLC will become wholly-owned subsidiaries of BlockchAIn Inc. The Co

    2/12/26 8:45:00 AM ET
    $SGN
    EDP Services
    Technology

    $ACON
    $ATXG
    $CLDI
    $CLEU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by GlycoMimetics Inc.

    SC 13G - GLYCOMIMETICS INC (0001253689) (Subject)

    11/27/24 2:22:44 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Virax Biolabs Group Limited

    SC 13G/A - Virax Biolabs Group Ltd (0001885827) (Subject)

    11/14/24 4:46:07 PM ET
    $VRAX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form SC 13G filed by VolitionRX Limited

    SC 13G - VOLITIONRX LTD (0000093314) (Subject)

    11/14/24 4:05:14 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACON
    $ATXG
    $CLDI
    $CLEU
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $ATXG
    $CLDI
    $CLEU
    Financials

    Live finance-specific insights

    View All

    Rail Vision CEO: Concluding 2025 with a Strong Cash Position, Zero Debt, Commercialization Gains, Global Expansion and Powerful Partnerships. Quantum Rail Innovation Ahead

    Ra'anana, Israel, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (NASDAQ:RVSN) ("Rail Vision" or the "Company"), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, today issued a corporate update to its shareholders from the Company's Chief Executive Officer, Mr. David BenDavid. Dear Shareholders, 2025 was a transformative year for Rail Vision. We are continuing the execution of our commercialization plan while we actively seek new opportunities that have the potential to provide us with sustained commercial momentum through strategic partnerships and technological leadership, while maintaining a strong balance she

    2/11/26 7:32:00 AM ET
    $RVSN
    Railroads
    Industrials

    VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update

    Conference call to take place on Friday, November 14 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., Nov. 10, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition") today announces that it will host a conference call on Friday, November 14 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the third quarter of 2025 and to provide a business update. Details of this event can be found below. Event:   VolitionRx Limited Third Quarter 2025 Earnings and Business Update Conference Call Date:     Friday, November 14, 2025Time:    8:30 a.m. U.S. Eastern Time/2.30 p.m. Central European Time U.S. & Canada Dial-in: 1-877-407-9716 (toll free)U.K. Dial-in: 0 800

    11/10/25 8:45:00 AM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

    Presented preclinical data at the American Society of Clinical Oncology (ASCO) on CLD-401 demonstrating biological efficacy IL-15 superagonist delivery to metastatic tumor sites and reduced immune clearance through engineered CD55 membrane expression; IND filing expected by the end of 2026Received FDA Fast Track Designation for CLD-201, a first-in-class stem-cell loaded intratumoral viral therapy for the treatment of patients with soft tissue sarcomaRaised $4.6 million gross proceeds through a warrant inducement offering with existing investors that further strengthens the company's balance sheet and extends its runway SAN DIEGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics

    8/8/25 4:15:00 PM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care